<!DOCTYPE html><html lang="en" ><head><meta http-equiv="Content-Type" content="text/html; charset=UTF-8"><meta name="theme-color" media="(prefers-color-scheme: light)" content="#f7f7f7"><meta name="theme-color" media="(prefers-color-scheme: dark)" content="#1b1b1e"><meta name="apple-mobile-web-app-capable" content="yes"><meta name="apple-mobile-web-app-status-bar-style" content="black-translucent"><meta name="viewport" content="width=device-width, user-scalable=no initial-scale=1, shrink-to-fit=no, viewport-fit=cover" ><meta name="generator" content="Jekyll v4.3.2" /><meta property="og:title" content="Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI" /><meta property="og:locale" content="en" /><meta name="description" content="Rationale and Objectives" /><meta property="og:description" content="Rationale and Objectives" /><link rel="canonical" href="https://clinicaltree.github.io/posts/cancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri/" /><meta property="og:url" content="https://clinicaltree.github.io/posts/cancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri/" /><meta property="og:site_name" content="Radiology Tree" /><meta property="og:type" content="article" /><meta property="article:published_time" content="2013-04-30T17:00:00+00:00" /><meta name="twitter:card" content="summary" /><meta property="twitter:title" content="Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI" /><meta name="twitter:site" content="@twitter_username" /><meta name="google-site-verification" content="RFHVRgQqK0eGjftEMCTDhsDrR8cJ_ZYcfCX52gXW8KM" /> <script type="application/ld+json"> {"@context":"https://schema.org","@type":"BlogPosting","dateModified":"2023-04-10T02:43:55+00:00","datePublished":"2013-04-30T17:00:00+00:00","description":"Rationale and Objectives","headline":"Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI","mainEntityOfPage":{"@type":"WebPage","@id":"https://clinicaltree.github.io/posts/cancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri/"},"url":"https://clinicaltree.github.io/posts/cancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri/"}</script><title>Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI | Radiology Tree</title><link rel="apple-touch-icon" sizes="180x180" href="/assets/img/favicons/apple-touch-icon.png"><link rel="icon" type="image/png" sizes="32x32" href="/assets/img/favicons/favicon-32x32.png"><link rel="icon" type="image/png" sizes="16x16" href="/assets/img/favicons/favicon-16x16.png"><link rel="manifest" href="/assets/img/favicons/site.webmanifest"><link rel="shortcut icon" href="/assets/img/favicons/favicon.ico"><meta name="apple-mobile-web-app-title" content="Radiology Tree"><meta name="application-name" content="Radiology Tree"><meta name="msapplication-TileColor" content="#da532c"><meta name="msapplication-config" content="/assets/img/favicons/browserconfig.xml"><meta name="theme-color" content="#ffffff"><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://fonts.gstatic.com" crossorigin><link rel="dns-prefetch" href="https://fonts.gstatic.com" crossorigin><link rel="preconnect" href="https://fonts.googleapis.com" ><link rel="dns-prefetch" href="https://fonts.googleapis.com" ><link rel="preconnect" href="https://cdn.jsdelivr.net" ><link rel="dns-prefetch" href="https://cdn.jsdelivr.net" ><link rel="stylesheet" href="https://fonts.googleapis.com/css2?family=Lato&family=Source+Sans+Pro:wght@400;600;700;900&display=swap"><link rel="preconnect" href="https://www.google-analytics.com" crossorigin="use-credentials"><link rel="dns-prefetch" href="https://www.google-analytics.com"><link rel="preconnect" href="https://www.googletagmanager.com" crossorigin="anonymous"><link rel="dns-prefetch" href="https://www.googletagmanager.com"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/css/bootstrap.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@fortawesome/fontawesome-free@6.2.1/css/all.min.css"><link rel="stylesheet" href="/assets/css/style.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.css"><link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/magnific-popup@1.1.0/dist/magnific-popup.min.css"> <script src="https://cdn.jsdelivr.net/npm/jquery@3.6.1/dist/jquery.min.js"></script> <script type="text/javascript"> class ModeToggle { static get MODE_KEY() { return "mode"; } static get MODE_ATTR() { return "data-mode"; } static get DARK_MODE() { return "dark"; } static get LIGHT_MODE() { return "light"; } static get ID() { return "mode-toggle"; } constructor() { if (this.hasMode) { if (this.isDarkMode) { if (!this.isSysDarkPrefer) { this.setDark(); } } else { if (this.isSysDarkPrefer) { this.setLight(); } } } let self = this; /* always follow the system prefers */ this.sysDarkPrefers.addEventListener('change', () => { if (self.hasMode) { if (self.isDarkMode) { if (!self.isSysDarkPrefer) { self.setDark(); } } else { if (self.isSysDarkPrefer) { self.setLight(); } } self.clearMode(); } self.notify(); }); } /* constructor() */ get sysDarkPrefers() { return window.matchMedia("(prefers-color-scheme: dark)"); } get isSysDarkPrefer() { return this.sysDarkPrefers.matches; } get isDarkMode() { return this.mode === ModeToggle.DARK_MODE; } get isLightMode() { return this.mode === ModeToggle.LIGHT_MODE; } get hasMode() { return this.mode != null; } get mode() { return sessionStorage.getItem(ModeToggle.MODE_KEY); } /* get the current mode on screen */ get modeStatus() { if (this.isDarkMode || (!this.hasMode && this.isSysDarkPrefer)) { return ModeToggle.DARK_MODE; } else { return ModeToggle.LIGHT_MODE; } } setDark() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.DARK_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.DARK_MODE); } setLight() { $('html').attr(ModeToggle.MODE_ATTR, ModeToggle.LIGHT_MODE); sessionStorage.setItem(ModeToggle.MODE_KEY, ModeToggle.LIGHT_MODE); } clearMode() { $('html').removeAttr(ModeToggle.MODE_ATTR); sessionStorage.removeItem(ModeToggle.MODE_KEY); } /* Notify another plugins that the theme mode has changed */ notify() { window.postMessage({ direction: ModeToggle.ID, message: this.modeStatus }, "*"); } flipMode() { if (this.hasMode) { if (this.isSysDarkPrefer) { if (this.isLightMode) { this.clearMode(); } else { this.setLight(); } } else { if (this.isDarkMode) { this.clearMode(); } else { this.setDark(); } } } else { if (this.isSysDarkPrefer) { this.setLight(); } else { this.setDark(); } } this.notify(); } /* flipMode() */ } /* ModeToggle */ const modeToggle = new ModeToggle(); </script><body data-topbar-visible="true"><div id="sidebar" class="d-flex flex-column align-items-end"><div class="profile-wrapper text-center"><div id="avatar"> <a href="/" class="mx-auto"> <img src="https://storage.googleapis.com/clinicalpub.com/images/favicon.png" alt="avatar" onerror="this.style.display='none'"> </a></div><div class="site-title"> <a href="/">Radiology Tree</a></div><div class="site-subtitle font-italic">Update every day the best and the lastest articles, books, journals, clinical cases, videos, images... for radiologist</div></div><ul class="w-100"><li class="nav-item"> <a href="/" class="nav-link"> <i class="fa-fw fas fa-home ml-xl-3 mr-xl-3 unloaded"></i> <span>HOME</span> </a><li class="nav-item"> <a href="/categories/" class="nav-link"> <i class="fa-fw fas fa-stream ml-xl-3 mr-xl-3 unloaded"></i> <span>CATEGORIES</span> </a><li class="nav-item"> <a href="/tags/" class="nav-link"> <i class="fa-fw fas fa-tag ml-xl-3 mr-xl-3 unloaded"></i> <span>TAGS</span> </a><li class="nav-item"> <a href="/archives/" class="nav-link"> <i class="fa-fw fas fa-archive ml-xl-3 mr-xl-3 unloaded"></i> <span>ARCHIVES</span> </a><li class="nav-item"> <a href="/about/" class="nav-link"> <i class="fa-fw fas fa-info-circle ml-xl-3 mr-xl-3 unloaded"></i> <span>ABOUT</span> </a></ul><div class="sidebar-bottom mt-auto d-flex flex-wrap justify-content-center align-items-center"> <button class="mode-toggle btn" aria-label="Switch Mode"> <i class="fas fa-adjust"></i> </button> <span class="icon-border"></span> <a href="https://github.com/clinicaltree" aria-label="github" target="_blank" rel="noopener noreferrer"> <i class="fab fa-github"></i> </a> <a href="https://twitter.com/twitter_username" aria-label="twitter" target="_blank" rel="noopener noreferrer"> <i class="fab fa-twitter"></i> </a> <a href="javascript:location.href = 'mailto:' + ['clinicalpub.team','gmail.com'].join('@')" aria-label="email" > <i class="fas fa-envelope"></i> </a> <a href="/feed.xml" aria-label="rss" > <i class="fas fa-rss"></i> </a></div></div><div id="topbar-wrapper"><div id="topbar" class="container d-flex align-items-center justify-content-between h-100 pl-3 pr-3 pl-md-4 pr-md-4"> <span id="breadcrumb"> <span> <a href="/"> Home </a> </span> <span>Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI</span> </span> <i id="sidebar-trigger" class="fas fa-bars fa-fw"></i><div id="topbar-title"> Post</div><i id="search-trigger" class="fas fa-search fa-fw"></i> <span id="search-wrapper" class="align-items-center"> <i class="fas fa-search fa-fw"></i> <input class="form-control" id="search-input" type="search" aria-label="search" autocomplete="off" placeholder="Search..."> </span> <span id="search-cancel" >Cancel</span></div></div><div id="main-wrapper" class="d-flex justify-content-center"><div id="main" class="container pl-xl-4 pr-xl-4"><div class="row"><div id="core-wrapper" class="col-12 col-lg-11 col-xl-9 pr-xl-4"><div class="post pl-1 pr-1 pl-md-2 pr-md-2"><h1 data-toc-skip>Cancelation of MRI Guided Breast Biopsies for Suspicious Breast Lesions Identified at 3.0 T MRI</h1><div class="post-meta text-muted"> <span> Posted <em class="" data-ts="1367341200" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 30, 2013 </em> </span> <span> Updated <em class="" data-ts="1681094635" data-df="ll" data-toggle="tooltip" data-placement="bottom"> Apr 10, 2023 </em> </span><div class="d-flex justify-content-between"> <span> By <em> <a href="">Karen S. Johnson MD</a> </em>, <em> <a href="">Jay A. Baker MD</a> </em>, <em> <a href="">Sheila S. Lee MD</a> </em>, <em> <a href="">Mary Scott Soo MD</a> </em> </span><div> <span class="readtime" data-toggle="tooltip" data-placement="bottom" title="1552 words"> <em>8 min</em> read</span></div></div></div><div class="post-content"><h2 id="rationale-and-objectives"><span class="mr-2">Rationale and Objectives</span><a href="#rationale-and-objectives" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>To determine the cancelation rate of magnetic resonance imaging (MRI)-guided procedures in suspicious breast lesions initially detected at 3.0 Tesla (T) MRI.</p><h2 id="materials-and-methods"><span class="mr-2">Materials and Methods</span><a href="#materials-and-methods" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>With institutional review board approval, a Health Insurance Portability and Accountability Act–compliant retrospective review of 117 suspicious 3.0 T MRI-detected lesions in 101 patients scheduled to undergo MRI-guided procedures was performed; informed consent was waived. Patient information, imaging features, and outcome data were collected and compared among completed and canceled procedures using Fisher’s exact test.</p><h2 id="results"><span class="mr-2">Results</span><a href="#results" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>MRI-guided breast biopsies were canceled in 13% (15/117) because of lesion nonvisualization, including three (20%) masses, one (1%) focus, and 11 (73%) areas of nonmasslike enhancement. Median lesion size was 1.1 cm. Sixty percent (9/15) of nonvisualized lesions were associated with minimal or mild background parenchymal enhancement at MRI. The nonvisualization rate was not associated with patient age, menopausal status, lesion type, size, breast density, or background parenchymal enhancement ( <em>P</em> &gt; .7 for each). No cancers were detected at original lesion sites in 14 (93%) patients undergoing follow-up imaging ( <em>n</em> = 11) or mastectomy ( <em>n</em> = 3) for cancer elsewhere; one (7%) was lost to follow-up.</p><h2 id="conclusion"><span class="mr-2">Conclusion</span><a href="#conclusion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p>The MRI-guided breast biopsy cancelation rate from nonvisualization of suspicious lesions originally detected with 3.0 T MRI scanning was 13%, similar to rates reported for lesions detected at 1.0 and 1.5 T MRI. No cancers were detected on follow-up imaging. Canceling MRI-guided biopsies because of lesion nonvisualization is a reasonable approach if measures are taken to ensure lesion resolution at the time of biopsy and at imaging follow-up.</p><p>Contrast-enhanced breast magnetic resonance imaging (MRI) is the most sensitive imaging modality for the detection of breast cancer. Because its superior sensitivity results from high-contrast resolution, suspicious lesions detected by MRI may not be visualized with other imaging modalities such as mammography and ultrasound . Histological sampling of suspicious, MRI-only-detected lesions must be performed using MRI-guided procedures such as MRI-guided vacuum-assisted core needle biopsy (VAB) and MRI-guided needle localization (NL). However, nonvisualization of a previously identified suspicious MRI-detected lesion in the breast on the day of MRI-guided intervention has been reported to occur between 5% and 15% of the time , resulting in procedure cancelation; most of these reports described diagnostic MRI exams performed on lower field strength 1.0 and 1.5 Tesla (T) MRI scanners .</p><p>Over the past 5–10 years, higher field strength 3.0 T MRI scanners have been used for cranial, musculoskeletal, and angiographic applications, showing promise for improving spatial resolution, contrast-to-noise ratios, and faster acquisition times . However, there is a paucity of data describing the use of higher field strength MRI for detection of breast lesions and subsequent procedure cancelation because of lesion nonvisualization during MRI-guided breast procedures. A recent study by Brennan et al describing cancelation of MRI-guided breast biopsy because of lesion nonvisualization included diagnostic MRI examinations performed using both 1.5- and 3.0-T scanners, but data pertaining to each magnetic field strength were not reported.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="materials-and-methods-1"><span class="mr-2">Materials and methods</span><a href="#materials-and-methods-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><h2 id="study-population"><span class="mr-2">Study Population</span><a href="#study-population" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-scanning-protocol"><span class="mr-2">MRI Scanning Protocol</span><a href="#mri-scanning-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="siemens-trio"><span class="mr-2">Siemens Trio</span><a href="#siemens-trio" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="ge-signa"><span class="mr-2">GE Signa</span><a href="#ge-signa" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="mri-guided-procedure-protocol"><span class="mr-2">MRI-guided Procedure Protocol</span><a href="#mri-guided-procedure-protocol" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="canceled-mri-guided-procedures"><span class="mr-2">Canceled MRI-guided Procedures</span><a href="#canceled-mri-guided-procedures" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="results-1"><span class="mr-2">Results</span><a href="#results-1" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="patients-characteristics"><span class="mr-2">Patients Characteristics</span><a href="#patients-characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p>Table 1</p><p>Patient and Imaging Characteristics</p><p>Characteristic Canceled Biopsies ( <em>n</em> = 15, Lesions Not Visualized, %) Successful Biopsies ( <em>n</em> = 98, Lesions Visualized, %) ∗ <em>P</em> Value Patient age .6 ≤49 years 8 (53) 40/86 (47) ≥50 years 7 (47) 46/86 (53) Median 42 51 Range 28–81 30–78 Menopausal status .6 Pre 7/15 (47) 43/84 (51) Post 8/15 (53) 34/84 (40) Unknown N/A 7/84 (8) Indication for breast MRI Screening 6/15 (40) 37/84 (44) Diagnostic 9/15 (60) 47/84 (56) Breast density 1.0 Extremely or heterogeneous 9/15 (60) 56/84 (61) Scattered or fatty 4/15 (27) 30/84 (30) No mammogram available 22/15 (13) 12/84 (10) Background enhancement .8 Minimal or mild 9/15 (60) 56/84 (67) Moderate of marked 6/15 (40) 28/84 (33) Lesion size .4 ≤10 mm 6/15 (40) 29/98 (30) &gt;10 mm 9/15 (60) 69/98 (70) Median 11 19 Range 5–84 3–114 Lesion type 1.0 Mass 3/15 (20) 20/98 (20) NMLE 11/15 (73) 71/98 (72) Focus 1/15 (7) 7/98 (7)</p><p>MRI, magnetic resonance imaging; NMLE, nonmasslike enhancement.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-characteristics"><span class="mr-2">Imaging Characteristics</span><a href="#imaging-characteristics" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CancelationofMRIGuidedBreastBiopsiesforSuspiciousBreastLesionsIdentifiedat30TMRI/0_1s20S1076633213000135.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CancelationofMRIGuidedBreastBiopsiesforSuspiciousBreastLesionsIdentifiedat30TMRI/0_1s20S1076633213000135.jpg" alt="Figure 1, Axial T1-weighted fat-suppressed contrast-enhanced magnetic resonance image (MRI) in a 61-year-old woman 7 years after lumpectomy and radiation therapy to the right breast for mucinous and invasive ductal carcinoma shows a 1.1-cm enhancing mass ( arrow ) in the right breast, which failed to enhance 7 days later at the time of planned MRI-guided vacuum-assisted core needle biopsy. Follow-up MRI scans performed at 6 months, 1 year, and 2 years after attempted biopsy showed no evidence of cancer at this location." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CancelationofMRIGuidedBreastBiopsiesforSuspiciousBreastLesionsIdentifiedat30TMRI/1_1s20S1076633213000135.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CancelationofMRIGuidedBreastBiopsiesforSuspiciousBreastLesionsIdentifiedat30TMRI/1_1s20S1076633213000135.jpg" alt="Figure 2, Axial T1-weighted fat-suppressed contrast-enhanced magnetic resonance image (MRI) in a 68-year-old woman with newly diagnosed ductal carcinoma in situ (DCIS) of the right breast shows an enhancing focus ( arrow ) that was not seen 23 days later at the time of planned MRI-guided vacuum-assisted core needle biopsy. Mastectomy specimen showed 4 cm of DCIS; this lesion was considered separate from the area of malignancy on imaging-histological review." class="lazyload" data-proofer-ignore></a></p><p><a href="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CancelationofMRIGuidedBreastBiopsiesforSuspiciousBreastLesionsIdentifiedat30TMRI/2_1s20S1076633213000135.jpg" class="popup img-link "><img data-src="https://storage.googleapis.com/dl.dentistrykey.com/clinical/CancelationofMRIGuidedBreastBiopsiesforSuspiciousBreastLesionsIdentifiedat30TMRI/2_1s20S1076633213000135.jpg" alt="Figure 3, Axial T1-weighted fat-suppressed contrast-enhanced magnetic resonance image (MRI) in a 55-year-old woman with newly diagnosed invasive ductal carcinoma of the left breast shows an area of linear nonmasslike enhancement ( arrows ) in the right breast, which was not seen 13 days later at the time of planned MRI-guided vacuum-assisted core needle biopsy. The patient returned in 12 months for a follow-up MRI and this finding was not present." class="lazyload" data-proofer-ignore></a></p><p>Table 2</p><p>Morphologic Descriptors of Masses ( <em>n</em> = 23)</p><p>Descriptor Number of Masses Visualized ( <em>n</em> = 20) Number of Masses Nonvisualized ( <em>n</em> = 3) Shape Round 8/23 (35) 0/23 (0) Oval 4/23 (17) 1/23 (1) Lobular 1/23 (1) 0/23 (0) Irregular 7/23 (30) 2/23 (9) Margins Smooth 5/23 (22) 0/23 (0) Irregular 12/23 (52) 3/23 (13) Spiculated 3/23 (13) 0/23 (0) All masses 20/23 (87) 3/23 (13)</p><p>Data in parentheses are percentages.</p><p>Table 3</p><p>Morphologic Descriptors of NMLE ( <em>n</em> = 86)</p><p>Descriptor Number of NMLE Visualized ( <em>n</em> = 75) Number of NMLE Nonvisualized ( <em>n</em> = 11) Focal 25/86 (29) 4/86 (5) Linear/ductal 30/86 (35) 5/86 (6) Segmental 7/86 (8) 1/86 (1) Regional 11/86 (13) 1/86 (1) Diffuse 2/86 (2) 0/86 (0) All NMLE 75/86 (9) 11/86 (13)</p><p>NMLE, nonmasslike enhancement.</p><p>Data in parentheses are percentages.</p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="imaging-and-histologic-follow-up"><span class="mr-2">Imaging and Histologic Follow-up</span><a href="#imaging-and-histologic-follow-up" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="discussion"><span class="mr-2">Discussion</span><a href="#discussion" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><p><a href="https://clinicalpub.com/app">Get Radiology Tree app to read full this article&lt;</a></p><h2 id="references"><span class="mr-2">References</span><a href="#references" class="anchor text-muted"><i class="fas fa-hashtag"></i></a></h2><ul><li><p>1. Berg W.A., Gutierrez L., NessAiver M.S., et. al.: Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer. Radiology 2004; 233: pp. 830-849.</p><li><p>2. Morris E.A., Liberman L., Dershaw D.D., et. al.: Preoperative MR imaging-guided needle localization of breast lesions. AJR Am J Roentgenol 2002; 178: pp. 1211-1220.</p><li><p>3. Hefler L., Casselman J., Amaya B., et. al.: Follow-up of breast lesions detected by MRI not biopsied due to absent enhancement of contrast medium. Eur Radiol 2003; 13: pp. 344-346.</p><li><p>4. Liberman L., Morris E.A., Dershaw D.D., et. al.: MR imaging of the ipsilateral breast in women with percutaneously proven breast cancer. AJR Am J Roentgenol 2003; 180: pp. 901-910.</p><li><p>5. Liberman L., Bracero N., Morris E., et. al.: MRI-guided 9-gauge vacuum-assisted breast biopsy: initial clinical experience. AJR Am J Roentgenol 2005; 185: pp. 183-193.</p><li><p>6. Hauth E.A., Jaeger H.J., Lubnau J., et. al.: MR-guided vacuum assisted breast biopsy with a handheld biopsy system: clinical experience and results in postinterventional MR mammography after 24 h. Eur Radiol 2008; 18: pp. 168-176.</p><li><p>7. Han B.K., Schnall M.D., Orel S.G., et. al.: Outcome of MRI-guided breast biopsy. AJR Am J Roentgenol 2008; 191: pp. 1798-1804.</p><li><p>8. Brennan S.B., Sung J.S., Dershaw D.D., et. al.: Cancellation of MR Imaging-guided breast biopsy due to lesion nonvisualization: frequency and follow-up. Radiology 2011; 261: pp. 92-99.</p><li><p>9. Saupe N., Prussmann K.P., Leuchinger R., et. al.: MR imaging of the wrist: comparison between 1.5- and 3-T MR imaging-preliminary experience. Radiology 2005; 234: pp. 256-264.</p><li><p>10. Phan C.M., Matsuura M., Bauer J.S., et. al.: Trabecular bone structure of the calcaneus: comparison of MR imaging at 3.0 and 1.5 T with micro-CT as the standard of reference. Radiology 2006; 239: pp. 488-496.</p><li><p>11. Heesakkers R.A.M., Futterer J.J., Hovels A.M., et. al.: Prostate cancer evaluated with ferumostran-10-enhanced T2*-weighted MR imaging at 1.5 and 3.0 T: early experience. Radiology 2006; 239: pp. 481-487.</p><li><p>12. Kijowski R., Blankenbaker D.G., Davis Kw, et. al.: Comparison of 1.5- and 3.0-T MR imaging for evaluating the articular cartilage of the knee joint. Radiology 2009; 250: pp. 839-848.</p><li><p>13. Runge V.M.: High field MRI – the new clinical standard?. [editorial] Invest Radiol 2009; 44: pp. 9.</p><li><p>14. American College of Radiology : Breast imaging Reporting and Data System Atlas (BI-RADS-MRI).2003.American College of RadiologyReston, VA</p><li><p>15. Johnson K.J., Baker J.A., Lee S.L., et. al.: Suspicious breast lesions detected at 3.0 T magnetic resonance imaging: clinical and histological outcomes. Acad Radiol 2012; 19: pp. 667-674.</p><li><p>16. Shetty M.K., Shah Y.P.: Sonographic findings in focal fibrocystic changes of the breast. Ultrasound Q 2002; 1: pp. 35-40.</p><li><p>17. Van den Bosch M.A., Daniel B.L., Mariano M.N., et. al.: Magnetic resonance imaging characteristic of fibrocystic change of the breast. Invest Radiol 2005; 7: pp. 436-441.</p><li><p>18. Chen J.H., Nalcioglu O., Su M.Y.: Fibrocystic change of the breast presenting as a focal lesion mimicking breast cancer in MR imaging. J Magn Reson Imaging 2008; 6: pp. 1499-1505.</p><li><p>19. Chen J.H., Liu H., Baek H.M., et. al.: Magnetic resonance imaging features of fibrocystic change of the breast. Magn Reson Imaging 2008; 9: pp. 1207-1214.</p></ul></div><div class="post-tail-wrapper text-muted"><div class="post-meta mb-3"> <i class="far fa-folder-open fa-fw mr-1"></i> <a href='/categories/academic-radiology/'>Academic Radiology</a>, <a href='/categories/volume-20/'>Volume 20</a>, <a href='/categories/issue-5/'>Issue 5</a></div><div class="post-tags"> <i class="fa fa-tags fa-fw mr-1"></i> <a href="/tags/journals/" class="post-tag no-text-decoration" >Journals</a> <a href="/tags/general-radiology/" class="post-tag no-text-decoration" >General Radiology</a></div><div class="post-tail-bottom d-flex justify-content-between align-items-center mt-3 pt-5 pb-2"><div class="license-wrapper"> This post is licensed under <a href="https://creativecommons.org/licenses/by/4.0/"> CC BY 4.0 </a> by the author.</div><div class="share-wrapper"> <span class="share-label text-muted mr-1">Share</span> <span class="share-icons"> <a href="https://twitter.com/intent/tweet?text=Cancelation%20of%20MRI%20Guided%20Breast%20Biopsies%20for%20Suspicious%20Breast%20Lesions%20Identified%20at%203.0%20T%20MRI%20-%20Radiology%20Tree&url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri%2F" data-toggle="tooltip" data-placement="top" title="Twitter" target="_blank" rel="noopener" aria-label="Twitter"> <i class="fa-fw fab fa-twitter"></i> </a> <a href="https://www.facebook.com/sharer/sharer.php?title=Cancelation%20of%20MRI%20Guided%20Breast%20Biopsies%20for%20Suspicious%20Breast%20Lesions%20Identified%20at%203.0%20T%20MRI%20-%20Radiology%20Tree&u=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri%2F" data-toggle="tooltip" data-placement="top" title="Facebook" target="_blank" rel="noopener" aria-label="Facebook"> <i class="fa-fw fab fa-facebook-square"></i> </a> <a href="https://t.me/share/url?url=https%3A%2F%2Fclinicaltree.github.io%2Fposts%2Fcancelation-of-mri-guided-breast-biopsies-for-suspicious-breast-lesions-identified-at-3-0-t-mri%2F&text=Cancelation%20of%20MRI%20Guided%20Breast%20Biopsies%20for%20Suspicious%20Breast%20Lesions%20Identified%20at%203.0%20T%20MRI%20-%20Radiology%20Tree" data-toggle="tooltip" data-placement="top" title="Telegram" target="_blank" rel="noopener" aria-label="Telegram"> <i class="fa-fw fab fa-telegram"></i> </a> <i id="copy-link" class="fa-fw fas fa-link small" data-toggle="tooltip" data-placement="top" title="Copy link" data-title-succeed="Link copied successfully!"> </i> </span></div></div></div></div></div><div id="panel-wrapper" class="col-xl-3 pl-2 text-muted"><div class="access"><div id="access-lastmod" class="post"><div class="panel-heading">Recently Updated</div><ul class="post-content pl-0 pb-1 ml-1 mt-2"><li><a href="/posts/neurometabolites-alteration-in-the-acute-phase-of-mild-traumatic-brain-injury-mtbi/">Neurometabolites Alteration in the Acute Phase of Mild Traumatic Brain Injury (mTBI)</a><li><a href="/posts/reinforcing-the-importance-and-feasibility-of-implementing-a-low-dose-protocol-for-ct-guided-biopsie/">Reinforcing the Importance and Feasibility of Implementing a Low-dose Protocol for CT-guided Biopsies</a><li><a href="/posts/rethinking-the-pgy-1-basic-clinical-year/">Rethinking the PGY-1 Basic Clinical Year</a><li><a href="/posts/single-injection-dual-phase-cone-beam-ct-dp-cbct-vascular-anatomy-assessment-and-occult-nodule-det/">Single Injection Dual-Phase Cone Beam CT (DP-CBCT) Vascular Anatomy Assessment and Occult Nodule Detection; Have We Reached the Focus?</a><li><a href="/posts/the-yellow-scale-is-superior-to-the-gray-scale-for-detecting-acute-ischemic-stroke-on-a-monitor-disp/">The Yellow Scale Is Superior to the Gray Scale for Detecting Acute Ischemic Stroke on a Monitor Display in Computed Tomography</a></ul></div><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="toc-wrapper" class="pl-0 pr-4 mb-5"><div class="panel-heading pl-3 pt-2 mb-2">Contents</div><nav id="toc"></nav></div><script src="https://cdn.jsdelivr.net/npm/tocbot@4.20.1/dist/tocbot.min.js"></script></div></div><div class="row"><div id="tail-wrapper" class="col-12 col-lg-11 col-xl-9 pl-3 pr-3 pr-xl-4 mt-5"><div id="related-posts" class="mb-2 mb-sm-4"><h3 class="pt-2 mb-4 ml-1" data-toc-skip>Further Reading</h3><div class="card-deck mb-4"><div class="card"> <a href="/posts/7-tesla-mprage-imaging-of-the-intracranial-arterial-vasculature/"><div class="card-body"> <em class="small" data-ts="1367341200" data-df="ll" > Apr 30, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>7 Tesla MPRAGE Imaging of the Intracranial Arterial Vasculature</h3><div class="text-muted small"><p> Purpose To intraindividually compare the delineation of intracranial arterial vasculature in nonenhanced versus contrast-enhanced magnetization prepared rapid gradient echo (MPRAGE) imaging at 7 T...</p></div></div></a></div><div class="card"> <a href="/posts/automated-registration-segmentation-and-measurement-of-metastatic-melanoma-tumors-in-serial-ct-sca/"><div class="card-body"> <em class="small" data-ts="1367341200" data-df="ll" > Apr 30, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Automated Registration, Segmentation, and Measurement of Metastatic Melanoma Tumors in Serial CT Scans</h3><div class="text-muted small"><p> Objectives Our goal was to evaluate a new software capability that integrates registration, segmentation and tumor measurement across serial exams within a picture archiving communication system (...</p></div></div></a></div><div class="card"> <a href="/posts/can-coronary-artery-anomalies-be-detected-on-ct-calcium-scoring-studies/"><div class="card-body"> <em class="small" data-ts="1367341200" data-df="ll" > Apr 30, 2013 </em><h3 class="pt-0 mt-1 mb-3" data-toc-skip>Can Coronary Artery Anomalies Be Detected on CT Calcium Scoring Studies?</h3><div class="text-muted small"><p> Purpose To determine whether coronary artery anomalies can be detected on noncontrast computed tomography (CT) coronary artery calcium scoring (CCS) studies. Materials and Methods A total of 126...</p></div></div></a></div></div></div><div class="post-navigation d-flex justify-content-between"> <a href="/posts/can-coronary-artery-anomalies-be-detected-on-ct-calcium-scoring-studies/" class="btn btn-outline-primary" prompt="Older"><p>Can Coronary Artery Anomalies Be Detected on CT Calcium Scoring Studies?</p></a> <a href="/posts/computed-tomography-density-histogram-analysis-to-evaluate-pulmonary-emphysema-in-ex-smokers/" class="btn btn-outline-primary" prompt="Newer"><p>Computed Tomography Density Histogram Analysis to Evaluate Pulmonary Emphysema in Ex-smokers</p></a></div></div></div></div><div id="search-result-wrapper" class="d-flex justify-content-center unloaded"><div class="col-12 col-sm-11 post-content"><div id="search-hints"><div id="access-tags"><div class="panel-heading">Trending Tags</div><div class="d-flex flex-wrap mt-3 mb-1 mr-3"> <a class="post-tag" href="/tags/general-radiology/">General Radiology</a> <a class="post-tag" href="/tags/journals/">Journals</a></div></div></div><div id="search-results" class="d-flex flex-wrap justify-content-center text-muted mt-3"></div></div></div></div><footer><div class="container pl-lg-4 pr-lg-4"><div class="d-flex justify-content-between align-items-center text-muted ml-md-3 mr-md-3"><div class="footer-left"><p class="mb-0"> © 2023 <a href="https://twitter.com/username">Clinical Team</a>. <span data-toggle="tooltip" data-placement="top" title="Except where otherwise noted, the blog posts on this site are licensed under the Creative Commons Attribution 4.0 International (CC BY 4.0) License by the author.">Some rights reserved.</span></p></div><div class="footer-right"><p class="mb-0">Using the <a href="https://jekyllrb.com" target="_blank" rel="noopener">Jekyll</a> theme <a href="https://github.com/cotes2020/jekyll-theme-chirpy" target="_blank" rel="noopener">Chirpy</a>.</p></div></div></div></footer><div id="mask"></div><a id="back-to-top" href="#" aria-label="back-to-top" class="btn btn-lg btn-box-shadow" role="button"> <i class="fas fa-angle-up"></i> </a><div id="notification" class="toast" role="alert" aria-live="assertive" aria-atomic="true" data-animation="true" data-autohide="false"><div class="toast-header"> <button type="button" class="ml-2 ml-auto close" data-dismiss="toast" aria-label="Close"> <span aria-hidden="true">&times;</span> </button></div><div class="toast-body text-center pt-0"><p class="pl-2 pr-2 mb-3">A new version of content is available.</p><button type="button" class="btn btn-primary" aria-label="Update"> Update </button></div></div><script src="https://cdn.jsdelivr.net/npm/simple-jekyll-search@1.10.0/dest/simple-jekyll-search.min.js"></script> <script> SimpleJekyllSearch({ searchInput: document.getElementById('search-input'), resultsContainer: document.getElementById('search-results'), json: '/assets/js/data/search.json', searchResultTemplate: '<div class="pl-1 pr-1 pl-sm-2 pr-sm-2 pl-lg-4 pr-lg-4 pl-xl-0 pr-xl-0"> <a href="{url}">{title}</a><div class="post-meta d-flex flex-column flex-sm-row text-muted mt-1 mb-1"> {categories} {tags}</div><p>{snippet}</p></div>', noResultsText: '<p class="mt-5">Oops! No results found.</p>', templateMiddleware: function(prop, value, template) { if (prop === 'categories') { if (value === '') { return `${value}`; } else { return `<div class="mr-sm-4"><i class="far fa-folder fa-fw"></i>${value}</div>`; } } if (prop === 'tags') { if (value === '') { return `${value}`; } else { return `<div><i class="fa fa-tag fa-fw"></i>${value}</div>`; } } } }); </script> <script src="https://cdn.jsdelivr.net/combine/npm/magnific-popup@1.1.0/dist/jquery.magnific-popup.min.js,npm/lazysizes@5.3.2/lazysizes.min.js,npm/clipboard@2.0.11/dist/clipboard.min.js"></script> <script src="https://cdn.jsdelivr.net/combine/npm/dayjs@1.11.6/dayjs.min.js,npm/dayjs@1.11.6/locale/en.min.js,npm/dayjs@1.11.6/plugin/relativeTime.min.js,npm/dayjs@1.11.6/plugin/localizedFormat.min.js"></script> <script defer src="/assets/js/dist/post.min.js"></script> <script src="https://cdn.jsdelivr.net/npm/bootstrap@4.6.2/dist/js/bootstrap.bundle.min.js"></script> <script defer src="/app.js"></script> <script defer src="https://www.googletagmanager.com/gtag/js?id=G-L66SLQK23K"></script> <script> document.addEventListener("DOMContentLoaded", function(event) { window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-L66SLQK23K'); }); </script>
